Companies / Czech Republic
Turkey Drives Sales Growth For Zentiva
July 2008 | Company News AlertCzech generics specialist Zentiva has said it expects sales to reach CZK8.9bn for the first half of 2008, a 32% year-on-year (y-o-y) growth. A continuing decline in sales in its key markets of Czech Republic and Romania was buffered by inclusion of sales from Eczacibaşi, the Turkish firm acquired by Zentiva in
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.
